TORONTO, Oct. 12, 2021 /PRNewswire/ -- Field Trip Health
Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) ("Field Trip"),
a leader in the development and delivery of psychedelic therapies,
today announced that Joseph del Moral, Co-Founder & CEO of
Field Trip, will present at the KCSA Psychedelics Investor
Conference to be held at VirtualInvestorConferences.com on
Wednesday, October 13th at
12:30pm ET.
To attend the conference, please register here.
For more information on the conference, or to schedule a
one-on-one meeting with the Field Trip management team, please
contact KCSA Strategic Communications at FieldTripIR@kcsa.com.
About Field Trip Health Ltd.
Field Trip is a global leader in the development and delivery of
psychedelic therapies. With our Field Trip Discovery division
leading the development of the next generation of psychedelic
molecules and conducting advanced research on plant-based
psychedelics and our Field Trip Health division building centers
for psychedelic therapies opening across North America and Europe along with the digital and
technological tools that will enable massive scale, we help people
in need with a simple, evidence-based way to heal and heighten
engagement with the world.
Learn more
at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.
Follow us on Twitter and Instagram: @fieldtriphealth.
To receive company updates about Field Trip and to be added to
the email distribution list please sign up here.
Cautionary Note Regarding Forward-Looking
Information
This release includes forward-looking information (within the
meaning of Canadian securities laws and within the meaning of the
United States Private Securities Litigation Reform Act of 1995)
regarding Field Trip and its business. Often but not always,
forward-looking information can be identified by the use of words
such as "expect", "intends", "anticipated", "believes" or
variations (including negative variations) of such words and
phrases, or state that certain actions, events or results "may",
"could", "would" or "will" be taken, occur or be achieved. Such
statements are based on the current expectations and views of
future events of the management of Field Trip, and are based on
assumptions and subject to risks and uncertainties. Although the
management of Field Trip believes that the assumptions underlying
these statements are reasonable, they may prove to be incorrect.
The forward-looking events and circumstances discussed in this
release may not occur and could differ materially as a result of
known and unknown risk factors and uncertainties affecting the
companies, including interest in the training program, interest in
the KAP Co-Op Program, uptake of the KAP Co-Op Program by
therapists and patients, the timing and results of its research and
development programs, approval of phase 1 human trials, if any, the
risk that future clinical studies may not proceed as expected or
may produce unfavorable results, the opening of additional clinics,
the COVID-19 epidemic, the medical clinic industry, market
conditions, economic factors, management's ability to manage and to
operate the business and the equity markets generally. Although
Field Trip has attempted to identify important factors that could
cause actual actions, events or results to differ materially from
those described in forward-looking statements, there may be other
factors that cause actions, events or results to differ from those
anticipated, estimated or intended. Accordingly, readers should not
place undue reliance on any forward-looking statements or
information. No forward-looking statement can be guaranteed. Except
as required by applicable securities laws, forward-looking
statements speak only as of the date on which they are made and
Field Trip does not undertake any obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy securities.
Neither the Toronto Stock Exchange, nor its Regulation Services
Provider, have approved the contents of this release or accept
responsibility for the adequacy or accuracy of this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/field-trip-health-ltd-to-present-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-13th-301397808.html
SOURCE VirtualInvestorConferences.com